220 related articles for article (PubMed ID: 193662)
21. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
[TBL] [Abstract][Full Text] [Related]
22. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
23. [Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody].
Cohen JH; Lenoir GM; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy G; Gougeon J
Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):3-7. PubMed ID: 6302824
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma.
Tan RS; Li JS; Grill SP; Nutter LM; Cheng YC
Cancer Res; 1986 Oct; 46(10):5024-8. PubMed ID: 3019519
[TBL] [Abstract][Full Text] [Related]
25. [EB virus-associated tumors-opportunistic B cell lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma].
Mizuno F
Nihon Rinsho; 1989 Feb; 47(2):481-6. PubMed ID: 2542671
[No Abstract] [Full Text] [Related]
26. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
[TBL] [Abstract][Full Text] [Related]
28. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma.
Kaschka WP; Klein G; Hilgers R; Skvaril F
Clin Exp Immunol; 1984 Jan; 55(1):14-22. PubMed ID: 6319056
[TBL] [Abstract][Full Text] [Related]
29. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.
Pearson G; Dewey F; Klein G; Henle G; Henle W
J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated Burkitt's lymphoma in India.
Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
[TBL] [Abstract][Full Text] [Related]
31. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
32. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
33. [Screening of dominant epitopes of antigens related to antibodies in the sera of patients with nasopharyngeal carcinoma].
Zhang Y; Xiao XB; Zhang CQ; Li JL; Sun Y; Ye YZ; Feng KT
Ai Zheng; 2004 Sep; 23(9):999-1004. PubMed ID: 15363190
[TBL] [Abstract][Full Text] [Related]
34. Detection of tumor-virus associated antibodies by mixed hemadsorption.
Gatti RA; Jonsson J
Boll Ist Sieroter Milan; 1974; 53(1):suppl:298. PubMed ID: 4368573
[No Abstract] [Full Text] [Related]
35. Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients.
Desgranges C; De-Thé G; Ho JH; Ellouz R
Int J Cancer; 1977 May; 19(5):627-33. PubMed ID: 193801
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
[TBL] [Abstract][Full Text] [Related]
37. [Cell membrane receptor of cultured cells derived from nasopharyngeal carcinoma, Burkitt's lymphoma and infectious mononucleosis].
Nishioka K; Tachibana T; Hirayama T; De Thé G; Klein G
Nihon Ishikai Zasshi; 1971 Jun; 65(11):1398-406. PubMed ID: 4326465
[No Abstract] [Full Text] [Related]
38. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
Hewetson JF; Levine PH; Neubauer RH; Rabin H
Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
[TBL] [Abstract][Full Text] [Related]
39. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals.
Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM
Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599
[TBL] [Abstract][Full Text] [Related]
40. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma.
Nonoyama M; Huang CH; Pagano JS; Klein G; Singh S
Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3265-8. PubMed ID: 4361687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
